About
Profile
Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was thi
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
LLY
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- White House fires CDC Director Monarez after refusal to resign; Four senior health officials step down
- CDC Director Susan Monarez refusing to resign, defying RFK Jr.
- Eli Lilly upgraded at HSBC after latest trial win for obesity pill
- Eli Lilly says Verzenio extended survival in late-stage breast cancer trial
- Chugai spikes after Eli Lilly trial win for obesity pill
- RFK Jr. says negotiations to lower drug prices are at an advanced stage
- How the top pharma companies are doing as Eli Lilly is S&P 500’s biggest gainer
- Eli Lilly obesity pill orforglipron ready for FDA submissions after another trial win
- Trump says he will lower drug prices by as much as 1500%
- Immuneering signs supply deal with Lilly to test atebimetinib plus olomorasib
- GLP-1 drugs such as Lilly’s Mounjaro and Novo’s Ozempic linked to lower cancer risk: study
- Eli Lilly begins executive search as neuro chief Anne White retires
- How does Viking’s oral obesity drug stand up to those of Eli Lilly and Novo?
- Eli Lilly, Novo Nordisk latest battle in GLP-1 market war: cash-paying customers
- Stocks retail investors love the most
- Insider trades: Eli Lilly, Boeing, Nike among notable names this week
- Short bets on S&P 500 Healthcare sector ease in July; Moderna remains most heavily shorted stock
- Eli Lilly partners with AI healthtech Superluminal Medicines
- Trump EO to bolster stockpile of active pharmaceutical ingredients for drugs
- Eli Lilly Mounjaro cost in UK to rise by as much as 170%
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| February 3, 2022 | 2.49 / 2.45 | 8B / 7.69B |
Beat! |
| October 26, 2021 | 1.94 / 1.96 | 6.77B / 6.64B |
Beat! |
| August 3, 2021 | 1.87 / 1.89 | 6.74B / 6.6B |
Beat! |
| April 27, 2021 | 1.87 / 2.12 | 6.81B / 6.93B | |
| January 29, 2021 | 2.75 / 2.37 | 7.44B / 7.27B |
Beat! |
| October 27, 2020 | 1.54 / 1.71 | 5.74B / 5.88B | |
| July 30, 2020 | 1.89 / 1.56 | 5.5B / 5.76B | |
| April 23, 2020 | 1.75 / 1.48 | 5.86B / 5.49B |
Beat! |
| January 30, 2020 | 1.73 / 1.52 | 6.11B / 5.91B |
Beat! |
| October 23, 2019 | 1.48 / 1.4 | 5.48B / 5.5B | |
| July 30, 2019 | 1.5 / 1.45 | 5.64B / 5.58B |
Beat! |
| April 30, 2019 | 1.33 / 1.31 | 5.09B / 5.2B | |
| February 6, 2019 | 1.33 / 1.34 | 6.44B / 6.29B |
Beat! |
| November 6, 2018 | 1.39 / 1.35 | 6.06B / 6.03B |
Beat! |
| July 24, 2018 | 1.5 / 1.3 | 6.36B / 6.05B |
Beat! |
| April 24, 2018 | 1.34 / 1.13 | 5.7B / 5.52B |
Beat! |
| January 31, 2018 | 1.14 / 1.07 | 6.16B / 5,934M |
Beat! |
| October 24, 2017 | 1.05 / 1.03 | 5.66B / 5.52B |
Beat! |
| July 25, 2017 | 1.11 / 1.05 | 5.82B / 5.60B |
Beat! |
| April 25, 2017 | 0.98 / 0.96 | 5.23B / - |
Beat! |